PMID: 11918083Mar 29, 2002Paper

Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines

Clinical & Experimental Metastasis
Guenadi KouniavskyMoshe Papa

Abstract

Several studies have shown that extracellular matrix reduces chemotherapeutic drugs-induced apoptosis in small cell lung cancer cells, myelomas and gliomas. We have investigated the protective effect of defined extracellular matrix components and of extracellular matrix from different cell types (fibroblasts, hepatocytes and intestinal epithelial cells) on the toxicity of three types of chemotherapeutic drugs on colon cancer cells. Human colon cancer cell lines LS174T and LiM6 were plated on plastic, on hepatocyte-derived ECM or on stromal ECM and in the presence of the antimetabolite 5-fluorouracil (5-FU). the topoisomerase I inhibitor camptothecin and the topoisomerase II inhibitor etoposide. We determined IC50 for the drugs for each of these culture conditions. We also determined the expression of the anti-apoptotic proteins bcl-2 and bcl-x (L) under these culture conditions. We found that stromal ECM protected LiM6 cells from the toxicity of etoposide and LS174T, but not LiM6 cells, from the toxicity of camptothecin. Collagen 1, fibronectin and fibroblast-derived ECM rendered LiM6 cells, but not LS174T, more sensitive to the harmful effect of 5-FU. Both colon cell lines had increased expression of anti-apoptotic proteins bc...Continue Reading

Citations

Oct 16, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Lina KrasnyYosef S Haviv
Oct 1, 2008·Expert Opinion on Drug Discovery·Matthias Kapischke, Alexandra Pries
Sep 14, 2007·International Journal of Radiation Biology·P S HodkinsonT Sethi
Mar 27, 2009·Breast Cancer Research and Treatment·Elena A Ostrakhovitch, Shawn S C Li
Oct 25, 2016·Journal of Cellular Physiology·Sara CrottiMarco Agostini
Mar 22, 2003·Expert Review of Anticancer Therapy·Tony Elliott, Tariq Sethi
Sep 8, 2004·International Journal of Cancer. Journal International Du Cancer·Wolfgang M SchmidtRobert M Mader
Jun 22, 2006·Future Oncology·Christina L Addison
Jul 27, 2017·Histopathology·Gordon G A HutchinsUNKNOWN QUASAR trial collaborators and the UK National Cancer Research Institute Colorectal Cancer Clinical Studies Group
Oct 23, 2014·Cancers·Marvin SchoberJ-Matthias Löhr
Oct 14, 2010·Cancer Research·Satoshi KohmoIchiro Kawase
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Corrie Lynn MessererMarcel B Bally
May 8, 2007·Cancer Research·Serenella M PupaElda Tagliabue
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John A ContiJohn P Iredale
Feb 3, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·José Alexandre FerreiraLúcio Lara Santos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.